Latest News for: ptpn2

Edit

Mondego Bio Announces Selection of a PTPN2 Inhibitor Clinical Candidate and Targets First-in-Human Trials in H1 2026

PR Newswire 22 Dec 2025
... of PTPN2 ... By selectively targeting PTPN2, we aim to investigate its potential role in modulating immune signaling pathways, including in combination with established immuno-oncology approaches.".
Edit

ChemDiv Extends Discovery and Early Development Partnership with Mondego Bio on Best-in-Class PTPN2 Immuno-Oncology Program

Ravalli Republic 25 Oct 2025
... best-in-class immuno-oncology program targeting PTPN2.
  • 1

Article Search

tools
×
×
×
×